11 /100
LOW RISK
Score updated Jul 14, 2026

FMS — Fresenius Medical Care AG Dilution Risk Tracker

Track FMS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track FMS — Get alerts when the score changes →

As of July 14, 2026, Fresenius Medical Care AG (FMS) has a DilutionWatch DilutionScore of 11/100, rated LOW dilution risk. Fresenius Medical Care AG has a market capitalization of $11.59B, 279.29M shares outstanding. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
19
💰 Cash Runway
0
📊 Float Risk
14
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for FMS.
🔔 Track FMS — Get forecast alerts →

💹 Market Data

Market Cap$11.59B
Shares Outstanding279.29M
Float184.69M
Cash$747.23M
Debt$7.81B
Short InterestN/A

🏛 Institutional Holdings

9.7% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track FMS for full holder detail →

📉 Short Interest

Short Interest2.92M
Days to Cover5.0
% of Float1.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2015
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for FMS Shareholders

Fresenius Medical Care AG (FMS) has a DilutionScore of 11/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for FMS shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for FMS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for FMS alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track FMS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking FMS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

LBTYA LBTYK AER AIG BABA

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for FMS
📊 FMS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 FMS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.